Description
Sunifiram (DM-235) is a piperazine-derived ampakine compound, structurally related to the racetam family. It exhibits high-affinity interactions with AMPA receptors, modulating glutamatergic neurotransmission and synaptic plasticity.
This compound undergoes hepatic metabolism primarily through hydroxylation and conjugation, with clearance occurring via renal excretion. Sunifiram has a high bioavailability and rapid onset of action, attributed to its lipophilic properties and efficient receptor binding.